All posts by imreal

Catalent Appoints Karen Santiago as Vice President and Chief Accounting Officer


Karen’s extensive background and deep finance expertise make her a valued addition to the team.

Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize the development, launch, and supply of better patient treatments across multiple modalities, today announced the appointment of Karen Santiago as Vice President and Chief Accounting Officer. Karen will become a member of the Company’s Executive Leadership Team and serve as its principal accounting officer.

Prior to joining Catalent, Karen spent 19 years with Bristol-Myers Squibb in various roles of increasing responsibility, including Senior Vice President & Corporate Controller, Principal Accounting Officer from 2018 to 2022, and Lead Enabling Functions and Finance Transformation from 2016 to 2018. Since 2013, she has served on the board of The Arc of New Jersey, the state’s largest organization advocating for and serving children and adults with intellectual and developmental disabilities and their families. She holds a Masters in Business Administration and a Bachelor of Science in Accounting from Rutgers University.

“I am delighted to welcome Karen to lead our accounting function,” commented Thomas Castellano, Senior Vice President, and Chief Financial Officer. “Her extensive background and deep finance expertise make her a valued addition to the team.”

Notes for Editors

About Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With the broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.

Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 19,000 includes more than 3,000 scientists and technicians.

Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

OrthoNu™ Launches as First Known Company Created to Advance the Orthodontic Industry as it Hits an Inflection Point Driving Massive Opportunity for Practices and Patients


News Image

“As orthodontists, we recognize that our industry is rapidly evolving. We need to look beyond the status quo to improve the patient experience in our offices and at home, and that is why I founded OrthoNu,” said Dr. Sima Yakoby Epstein, DMD, OrthoNu Founder and CEO.

Created by an orthodontist, OrthoNu™, the first company entirely focused on developing new, dynamic science-driven discovery to support the orthodontic community and patients, is redefining the orthodontic standard of care with a new category of self-care solutions for real life. OrthoNu is delivering a full line of premium, professional-grade self-care tools, including Tweakz® for Braces and Tweakz® for Aligners, to meet the daily oral care needs of orthodontic patients and enhance practice efficiencies.

The orthodontics market is undergoing a seismic shift due to the massive growth in patients of all ages seeking orthodontic treatments and the occurrence of new technologies. Still, nearly 9 in 10 patients experience urgent oral care issues during the course of their treatment.1 OrthoNu gives patients the ability to better care for their oral health so unplanned and urgent appointments can be minimized. This provides orthodontic practices with the opportunity to create office efficiencies such as reduced use of clinical chair time and additional tools sterilizations, so care teams have more time to see scheduled patients, potentially leading to greater profitability.

“As orthodontists, we recognize that our industry is rapidly evolving. We need to look beyond the status quo to improve the patient experience in our offices and at home, and that is why I founded OrthoNu,” said Dr. Sima Yakoby Epstein, DMD, OrthoNu Founder and CEO. “By embracing and staying ahead of this shift, we’ll create efficiencies that will enable our practices to do more for more patients and ultimately have an even greater impact on each patient’s overall health.”

Patients in orthodontic treatment are in a constant inflammatory state with an ever-changing microbiome, making it critical to maintain comfort and oral hygiene. OrthoNu is working with renowned researchers, medical centers, and developers of orthodontic concepts and solutions, to ensure the OrthoNu products are scientifically driven and of the highest quality.

“We are pleased to collaborate with OrthoNu to test and validate the science that could enable better sensors, so that it can be applied to their unique line of orthodontic care products to establish oral health and potential preventive medicine biomarkers for disease states found in the mouth,” said Shu Yang PhD, Joseph Bordogna Professor and Chair of the Department of Materials Science and Engineering in the University of Pennsylvania’s School of Engineering and Applied Science. “This research will help us identify and discover new ways that the orthodontic experience can be optimized to improve patient experience, outcomes, and overall health.” Dr. Hyun (Michel) Koo, co-founder and co-director of the Center for Innovation & Precision Dentistry (CiPD), a joint initiative from Penn Dental and Penn Engineering, will be providing inputs to Shu Yang’s team to help the phases of research move forward.

OrthoNu’s line of products focus on emergency care, oral hygiene, oral aesthetics, and oral health, reducing the massive impact of emergency visits and elevating the patient experience throughout treatment.

For more information about OrthoNu including to see What’s #NU4U, please visit http://www.OrthoNu.com.

About OrthoNu™

OrthoNu is the first company to focus on driving innovation in oral care to support both patient experience and practice efficiencies. OrthoNu is creating a new category of professional-grade, self-care products, including its hero product Tweakz® for Braces and Aligners, for orthodontists to provide to their patients, redefining the orthodontic standard of care. With an advisory board of industry leaders and developing partnerships with the University of Pennsylvania’s School of Dental Medicine, Center for Innovation & Precision Dentistry,

and the Penn Center for Innovation, OrthoNu is committed to advancing the science of oral health, which has a significant role in improving overall health.

1 Bilder L., Hazan-Molina H., Aizenbud D. Medical emergencies in a dental office: inhalation and ingestion of orthodontic objects. J Am Dent Assoc. 2011;142:45–52

# # #

Share article on social media or email:

Mindray to Reveal Innovative Emergency Medicine Solutions Live at ACEP22 Scientific Assembly


TE X Ultrasound System

TE X Ultrasound System

Mindray will be exhibiting at ACEP22 in Booth 1224 to highlight their latest advancements in Emergency Medicine, including the live debut of the TE X Ultrasound System.

Mindray, a global developer of healthcare technologies and solutions for ultrasound, patient monitoring, and anesthesia, announced today that they are exhibiting at the American College of Emergency Physicians (ACEP) 2022 Scientific Assembly at the Moscone Center in San Francisco, CA, October 1-3. They will highlight their latest advancements in Emergency Medicine, including the live debut of the TE X Ultrasound System, a new offering that is “changing your perspective” in the Point of Care Ultrasound (POCUS) market. All ACEP attendees are invited to visit Booth 1224 to learn more about Mindray’s innovative Emergency Medicine solutions.

“Our TE-Series Ultrasound Family continues to push the boundaries of Point of Care Ultrasound, providing Emergency Medicine clinicians with the technology of tomorrow, today,” said Jim Berry, Sr. Marketing Manager, Point of Care Ultrasound. Berry continued, “The diversity of our portfolio carries on the Mindray legacy, showcasing our tradition of disruptive technology and further establishing us as an industry leader in POCUS. The new TE X System brings ultrasound to unprecedented heights, underscoring our dedication to the Emergency Medicine market and our continuous innovation to drive the market forward.”

Mindray’s ACEP22 Assembly will highlight its comprehensive solutions for Emergency Medicine, including two headliners, the TE X Ultrasound Machine and the BeneVision N1 Patient Monitor. The touch-based TE X Ultrasound System is powered by Mindray’s proprietary software-based beamformer Zone Sonography Technology+ (ZST+) and offers the most robust suite of AI-powered Smart Tools to help expedite clinical decision-making and achieve reproducibility between exams. The TE X offers an industry-first wireless transducer that connects to the TE X System or can be used independently with a mobile device. Mindray will feature live scanning with the TE X Ultrasound in their booth throughout the show. BeneVision N1 serves as a comprehensive multi-parameter module, a powerful transport monitor, and a versatile bedside monitor – all in one. The N1’s patient-centric design mobilizes patients supporting improved workflow to and from the Emergency Department, providing access to real-time patient data, where and when needed.

Mindray understands the need for clinicians to deliver focused and efficient patient care in the Emergency Medicine space. With a portfolio that offers leading-edge technology and everyday applications to meet the diverse demands of the Emergency Department and the evolving needs of patient populations, Mindray continues to push the boundaries of what is possible. These innovative, accessible solutions offer sophisticated tools and technologies that empower clinicians to streamline workflow, minimize the risk of infection, and provide the highest quality of care now and in the future.

About Mindray

Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: medical imaging, patient monitoring and life support, and in-vitro diagnostics. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California, with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.

Share article on social media or email:

Maine Bankers Association Focuses on Wellness for Members


News Image

“Being able to focus on the employees, and their own personal, physical and mental goals in health and wellness is extremely important to our members. We have offered a wellness program for more than 15 years and we are excited about this new partnership.”

The Maine Bankers Association Employee Benefits Trust has formed a partnership with OMC Wellness that will offer wellness strategy and programming to members of the Trust. OMC Wellness provides population health management, health coaching, and proprietary wellness software, all of which are being made available to members of the Benefits Trust and the members’ 3000 employees throughout the state.

“As nearly every industry in the country is struggling with staffing challenges, we’re all thinking about what is most important to the team within our members’ offices,” said Marcia Ferguson, Senior Vice President of insurance of the Maine Bankers Association. “Banks offer good paying jobs with good benefits and truly value the health and well-being of their employees. Being able to focus on the employees, and their own personal, physical and mental goals in health and wellness is extremely important to our members. We have offered a wellness program for more than 15 years and we are excited about this new partnership.”

OMC Wellness was founded in Leeds, ME in 1996 and currently operates as a subsidiary of Wellness Workdays. OMC Wellness works with businesses and organizations, large and small, on effective wellness programs. Using physician-driven approaches and the science of designing and delivering behavior change to drive results, OMC Wellness helps design initiatives that maximize employee recruitment, retention, and engagement.

“We know that the pandemic has taken a toll on mental health and the overall stress of individuals in every industry,” said Debra Wein, CEO and founder of Wellness Workdays. “The Maine Bankers Association takes the wellness and health of their members’ employees seriously. OMC Wellness specializes in customizing wellness approaches for organizations of all sizes. Whether it’s a bank with a handful of employees, or the largest bank in Maine with dozens of locations, we are ready to provide each bank with the perfect blend of solutions to engage every employee.”

OMC Wellness, a subsidiary of Wellness Workdays, is based in Maine and works with clients across the United States. The Maine Bankers Association represents the Maine banking industry, eighteen of its 35 member institutions participate in the Benefits Trust with 3000 employees statewide.

“We take the responsibility of promoting wellness seriously,” said Wein. “Our focus is on promoting outcomes for our client partners. Using a unique, hands-on approach, with a specific focus on behavior change, we are able to help organizations and individuals succeed.”

OMC Wellness focuses on six elements as defined by the Harvard Business School to maximize outcomes. Multi-level leadership, accessibility, program scope & quality, communications, organization alignment and partnerships are used to bring the total health of participating employees to maximum potential.

“Our four-step process to drive results is unique,” said Wein. “The results have been proven. It works, and considering everything happening around us, the timing for the Maine Bankers Association couldn’t be better.”

More details about OMC Wellness can be found at http://www.omcwellness.com

More details about the Maine Bankers Association can be found at http://www.MaineBankers.com.

Share article on social media or email:

Lane Health Announces Partnership with Burnham & Flower Insurance Group to Offer Innovative Spending Account Solutions


“With the activated Advance¹ supplying real-time, on-demand funds to employees, Burnham & Flower’s clients can give their employees greater peace of mind, knowing they’ll have help paying for healthcare expenses when they need it,” noted Brad Gambill, Co-founder & CEO of Lane Health.

Lane Health is thrilled to announced they have entered into an agreement with Burnham & Flower Insurance Group to offer an Advance¹ line of credit, issued by WebBank, for virtually all Burnham & Flower’s HSA account holders as they seek to aggressively grow their position in the marketplace. The Advance¹ line of credit will be powered through Lane Health.

The activated Advance¹ line of credit provides access to on-demand funds for employees with benefit spending accounts and allows them to repay over 12 months through the convenience of payroll deduction. By repaying with pre-tax dollars through their HSA, employees can save up to 20% or more² on out-of-pocket costs, and employers save on payroll taxes. Employers bear no risk, including on uncollectible Advances¹, and the Advance¹ is offered at no cost to them.

“The Advance¹ line of credit makes us different than any other provider in the spending account space,” noted Brad Gambill, Co-founder & CEO of Lane Health. “With the activated Advance¹ supplying real-time, on-demand funds to employees, Burnham & Flower’s clients can give their employees greater peace of mind, knowing they’ll have help paying for healthcare expenses when they need it. And employees can be confident selecting a High Deductible Health Plan even without making any initial HSA contributions. This is a very easy and valuable benefit to offer its clients and their employees.”

“Burnham & Flower Insurance Group is excited to partner with Lane Health by offering access to the Advance¹ line of credit to our HSA solution and help provide financial security to employees facing large or unexpected healthcare expenses,” said Brian Ackerman, CEO of Burnham & Flower Insurance Group. “This solution addresses the key issues related to the accessibility and affordability of healthcare for so many employees. It answers a significant problem with the financial burden of healthcare, and we are excited that our customers will be able to offer this groundbreaking solution.”

About Lane Health

Lane Health helps make healthcare more accessible and affordable by offering a full suite of consumer health spending accounts, all on a single Card with a Heart®. And through the activated Advance line of credit¹, issued by WebBank, Lane Health members gain access to an on-demand safety net to help them pay for their healthcare expenses, helping them sleep better at night. Lane Health’s industry trailblazing and rapid growth through broker and strategic partner distribution has been recognized with the Alegeus APEX Awards for Innovation and Growth in 2021 and 2022. Visit http://www.LaneHealth.com to learn more.

About Burnham & Flower

Burnham & Flower Insurance Group was founded in 1966 and has grown into six separate corporations serving thousands of clients in the public and private sectors. Burnham & Flower is currently one of the largest municipal insurance organizations in the country and is also part of Acrisure, one of the fastest growing brokerages in industry history with locations across the globe.  Burnham & Flower Third Party Administers COBRA, FSAs, HSAs, HRAs, ICHRAs and Lifestyle Benefits for their Acrisure Agency Partners.  Burnham & Flower’s corporate office is in Kalamazoo, MI and they can be reached at mailto:jschmitz@bfgroup.com [jschmitz@bfgroup.com __title__ null] or https://www.acrisure-tpa.com.

–

¹ Advances issued by WebBank

² Assuming 7.65% payroll taxes and 12.35% combined federal/state tax rate; savings will vary based on individual tax situations

Share article on social media or email:

Lehigh Valley Eye Center, a OCLI Vision practice, Welcomes New Glaucoma Specialist to Their Expanding Team of Eye Care Professionals


“I am honored to expand the glaucoma team and look forward to giving my patients access to advanced eye care services and technology, ensuring they are getting the treatment they need for all their eye care goals.”

OCLI Vision is excited to welcome Bonny Lee, MD, a fellowship-trained, board-certified glaucoma specialist to its growing team of eye care professionals at the Lehigh Valley Eye Center, an OCLI Vision practice in Bethlehem. The eye care clinic is located at 3535 High Point Boulevard, Suite 800 Bethlehem, PA 18017.

Dr. Lee received her bachelors from Cornell University, majoring in biological sciences and economics. She obtained her medical degree from the University of Queensland, Ochsner Clinical School. She interned at the Ochsner Clinic foundation in New Orleans in internal medicine and completed her ophthalmology residency at Louisiana State University. Dr. Lee completed her glaucoma fellowship at New York University.

Dr. Lee is board certified by the American Board of Ophthalmology and is a member of the American Glaucoma Society, Chandler Grant Glaucoma Society, American Society of Cataract and Refractive Surgery, The Association for Research in Vision and Ophthalmology, and the American Academy of Ophthalmology.

“I’m grateful to be joining the world-class team of eye care professionals in the Lehigh Valley,” stated Dr. Lee. “I am honored to expand the glaucoma team and look forward to giving my patients access to advanced eye care services and technology, ensuring they are getting the treatment they need for all their eye care goals.”

OCLI Vision is a leading ophthalmology practice whose growth is supported by the management and administrative services of Spectrum Vision Partners (SVP), an organization serving many of the top ophthalmology groups and ambulatory eye surgery centers in New York, New Jersey, Connecticut, Pennsylvania, and West Virginia.

About OCLI Vision

Founded in 1997, OCLI Vision (https://www.ocli.net) is one of the leading ophthalmology and optometry practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania, and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care, who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.

About Spectrum Vision Partners

Spectrum Vision Partners (SVP) (http://www.spectrumvisionpartners.com) is a leading management services organization, serving the ophthalmology sector. With nearly 1,300 employees providing world-class practice management and administrative solutions to a network of nationally renowned, multi-specialty ophthalmologists in New York, New Jersey, Connecticut, Pennsylvania and West Virginia, SVP supports over 45 clinic locations, five state-licensed ambulatory surgery centers, and over 125 surgeons, doctors, and other medical professionals. SVP provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management and information technology. The company’s corporate service center is located at 825 East Gate Boulevard, Suite 111, Garden City, NY 11530.

Share article on social media or email:

American Business Systems Partners With Schooley Mitchell


Schooley-Mitchell

Schooley-Mitchell

ABS owners can help medical professionals do their jobs more efficiently while we provide a blueprint for entrepreneurial success. Our partnerships, like the one with Schooley Mitchell, increase the likelihood of success exponentially.

American Business Systems, or ABS, guides entrepreneurs as they set up their own medical billing and patient-management businesses.

ABS accomplishes this through its innovative business model, as well as through partnerships with other firms. One such partner is Schooley Mitchell, the largest independent cost reduction consulting firm in North America.

Partnerships like the one with Schooley Mitchell provide ABS’s client-entrepreneurs with industry-leading billing and complementary software services. In short, it is business ownership with minimal downside and maximum training and support so that industrious people can achieve success on their terms, with access to the best minds in the business.

“No one succeeds alone,” said Phillips. “Our goal at ABS is to ensure entrepreneurs have every tool possible so that they can succeed in a business with almost unlimited growth potential.

“ABS owners can help medical professionals do their jobs more efficiently while we provide a blueprint for entrepreneurial success. Our partnerships, like the one with Schooley Mitchell, increase the likelihood of success exponentially.”

Schooley Mitchell reduces essential business service expenses by an average of 28% and have delivered over $540 million in documented savings to its 26,000+ clients to date.

“This is a powerful business partnership that allows our individual entrepreneurs to provide their physician and dentist clients with an array of services beyond billing,” Phillips said. “It is evidence of our company’s original commitment to easing medical billing responsibilities, and our latest commitment to build a generation of entrepreneurs who can live life on their own terms.”

Phillips concluded by noting this is just one of the many partnerships ABS has with companies providing its clients with the best and most innovative services to assist the medical community, and, in some cases, other industries as well.

For more information on how to become an ABS’s Business Owner and begin a career providing services to the medical community, interested entrepreneurs should go to the ABS website at https://absystems.com/ and download “5 Secrets of Success.”

-30-

ABOUT AMERICAN BUSINESS SYSTEMS

American Business Systems offers aspiring individuals a template for business ownership in the medical billing field with minimal downside and maximum training and support so that hard-working people can achieve success on their terms. For more information, visit http://www.absystems.com.

ABOUT SCHOOLEY MITCHELL

Schooley Mitchell is the largest independent cost reduction consulting firm in North America, with offices from coast-to-coast in the United States and Canada. On average, the company reduces essential business service expenses by 28% and have delivered over $540 million in documented savings to clients to date. For more information, visit https://www.schooleymitchell.com/thubbard.

Share article on social media or email:

EverythingALS Joins Forces with Aural Analytics, FeetMe, ZEPHYRx and Others for a First-Of-Its-Kind ALS Research Study


“This is the first time that companies are working in conjunction to capture quantifiable data that could change how ALS and other neurodegenerative diseases like ALS, Alzheimer’s and Parkinson’s are treated and diagnosed.”

EverythingALS, a patient-focused non-profit that brings together people living with ALS, caregivers, physicians, researchers, and pharmaceutical companies to collaborate on an open innovation platform using cutting-edge technologies and data science to improve progression measurements for neurological disease like Amyotrophic Lateral Sclerosis (ALS), has initiated a new study, The Radcliff Study, with partners in the quest to find a diagnosis, treatment, and cure for ALS. EverythingALS is teaming up with Aural Analytics, a leader in clinical-grade speech analytics, FeetMe, a medical device company that produces smart and connected insoles for improved running, walking and gait analysis, ZEPHYRx, a leading provider of end-to-end remote respiratory monitoring solutions, and a major pharmaceutical company. The Radcliff Study is a novel research-as-a-feasibility study to inform the likelihood of success for a pre-competitive collaboration focused on developing an end-to-end digital alternative for the ALSFRS-R that supports clinically meaningful outcomes tailored for use in ALS. There is not one test or procedure to establish the diagnosis of ALS and there is also no known cure or treatment options available.

The Radcliff Study is a multidisciplinary study focused on gait analysis, pulmonary function testing, and speech analytics to make strides towards a digital biomarker. The study uses AI, remote patient monitoring technologies, and algorithms to determine possibly clinically meaningful characteristics for persons living with ALS.

The research study requires participants to partake in a series of tasks that help track and monitor changes in speech, walking and breathing. Unlike traditional medical tests that need to be done in a medical office, all Radcliff Study components can be completed at home.

“EverythingALS is excited to work with Aural Analytics, FeetMe and ZEPHYRx on this unique study,” said Indu Navar, Founder of the Peter Cohen Foundation and CEO of EverythingALS. “This is the first time that companies are working in conjunction to capture quantifiable data that could change how ALS and other neurodegenerative diseases like ALS, Alzheimer’s and Parkinson’s are treated and diagnosed.”

The Radcliff study is named after Tom Radcliff, an ALS patient who fought to find a cure for ALS before passing away from the disease. “It’s an honor to know Tom’s legacy is continuing on through the study,” said Erin Radcliff, Tom’s wife. “He fought tooth and nail to help find a cure for ALS before he passed and more importantly, he cared about other ALS patients, having been through the treacherous diagnosis phase himself and then living with the disease for a year before he passed. The Radcliff Study honors his legacy by putting the focus on patients and allowing them to be heard. It’s amazing what strength in numbers can accomplish, especially in the ALS community.”

Aural Analytics will be providing tech that can analyze participant’s speech patterns. “We are looking forward to the impact of the Radcliff Study through the partnership with EverythingALS and the participating organizations,” said Judy Smythe, Chief Executive Officer of Aural Analytics. “Speech is a leading objective data stream that is highly sensitive to subtle motor changes in the speech of ALS participants. We are highly optimistic about the powerful combination of speech, gait, and pulmonary function.”

Participants of the Radcliff Study will be wearing FeetMe smart insoles for gait analysis. “We want to support this research effort to build new and innovative disease specific markers and potentially help to detect earlier signs of ALS with non-invasive digital technology disease evolution. It will be powerful to see the combination of multiple high quality data sources in this multimodal study to improve disease knowledge,” said Alexis Mathieu, Founder and Senior Advisor of FeetMe. “Motor impairment is a common feature across neurodegenerative disorders, and we are expecting to see subtle changes thanks to real world data collection.”

The ZEPHYRx solution will collect pulmonary function test data from participants and share that data with the study team in real-time through a cloud-based platform. “Having the ability to perform a pulmonary function test at any moment and from the comfort of home is fundamental for study participants with neuro-muscular diseases like ALS,” said Mike DiCesare, President of ZEPHYRx. “We’re thrilled to be a part of this research study as spirometry is an important indicator of ALS disease progression.”

Some of the inclusion criteria are:

· Are 18 or older

· Can provide informed consent

· Fully able to communicate

· Able to read and write intelligibly in English

· Own a smartphone and able to download and consent to App usage without assistance

· Independently ambulate without gait assistive devices

· Able to ascent and descend stairs independently safely

· Have been diagnoses with ALS by a neuromuscular specialist or people who have ALS as a consideration for a cause of their symptoms

Recruitment will open shortly, and anyone interested in participating can get more information and apply at: http://everythingals.org/research.

About EverythingALS

EverythingALS is a patient-focused non-profit, part of Peter Cohen Foundation, a 501(3)c organization, bringing technological innovations and data science to support efforts — from care to cure — for people with ALS, by offering an open-data platform for direct engagement with patients, caregivers, researchers, and drug companies. For more information, please visit: http://www.EverythingALS.org

About Aural Analytics

Aural Analytics is the industry’s leading speech neuroscience company harnessing the clinical utility of the world’s speech across the age range and around the world. Their suite of applications and embeddable SDKs and APIs are available in 25 languages across Android, iOS, and the web are easy to use, secure, and provide robust, clinically relevant, interpretable, and validated metrics reflecting the neurological and respiratory health of its users. For more information, please visit:

http://www.auralanalytics.com/

About FeetMe

FeetMe is a certified medical device company developing smart medical wearables to improve mobility based on connected insoles. The innovative technology from FeetMe allows gait and posture analysis in real-time and real-life conditions. The technology combines pressure sensors, motion sensors and learning algorithms to analyze patients’ functional capacity, as well as empower rehabilitation among sufferers of gait disorders. FeetMe proposes the world’s first and most advanced technology platform for real-world disease diagnostics, monitoring and rehabilitation based on movement data. For more information, please visit:

http://www.feetmehealth.com/

About ZEPHYRx

ZEPHYRx is a leading provider of end-to-end remote respiratory monitoring solutions. Our solutions combine a cloud-based provider dashboard with real-time video coaching, patient mobile app, and MIR’s FDA-cleared spirometer. Our mission is to empower patients to actively manage and improve their own respiratory health through leading-edge technology and gamification. For more information, please visit: http://www.zephyrx.com/

Gaize and dicentra Open Participant Enrolment for VR Cannabis Impairment Clinical Trial


News Image

“Our mission is to improve the lives of millions, worldwide. Working with great partners like Gaize helps make this mission a success, by providing the clinical evidence needed to bring Impairment Detection Devices like this to market, and make our roads safer.” – Peter Wojewnik, Partner, dicentra

dicentra, a world-renowned Contract Research Organization (CRO) and global consulting firm, is pleased to announce that it has opened participant enrolment for a new groundbreaking cannabis impairment study with its client, Gaize. The study is seeking 350 participants to volunteer at dicentra’s clinical research site in Toronto, Canada.

Cannabis use can negatively impact a driver’s ability to safely operate a motor vehicle by affecting motor skills, slowing reaction time, and impairing short-term memory and concentration. Despite this, according to research done at Western University, drug-impaired driving increased by 43% in the first full year after Canada’s federal legalization of cannabis. This statistic is further compounded by findings from 2021’s Canadian Cannabis Survey that one in four cannabis users admit to having operated a vehicle while under the influence of cannabis.

Approved alcohol screening devices (ASDs) have been available to law enforcement agencies for over four decades. These devices provide an easy means of ascertaining both the presence and the concentration of alcohol at a roadside traffic stop. Unlike alcohol, there are currently no comparable screening devices to ascertain the level of cannabis impairment. In fact, studies suggest that the Standardized Field Sobriety Test (SFST), and roadside oral fluid screening may be unreliable measures of cannabis impairment.

The Gaize Cannabis Impairment Detection Device administers an automated standardized field sobriety eye test and captures high-definition eye movement video. The eye movement data is used to determine cannabis intoxication and the captured footage is securely stored and can later be used as evidence to demonstrate the signs and symptoms of impairment. This product simultaneously tackles the issue of safety, accuracy, and fair and reliable evidence in potential prosecution and defense cases.

“The implications of this study on road safety are immense. That’s what makes studies like this one so important,” says Peter Wojewnik, Partner, at dicentra. “Part of our mission is to improve the lives of millions, worldwide. Working with great partners like Gaize helps make this mission a success, by providing the clinical evidence necessary to bring Cannabis Impairment Detection Devices like this to market, and help make our roads safer.”

“The Gaize Cannabis Impairment Detection Device was designed specifically to provide a safe and reliable investigational device for cannabis detection,” says Ken Fichtler, CEO at Gaize. “Our proprietary cannabis detection software is the first of its kind to be used in a VR headset. This study will help us to determine how safe, effective, and reliable our device is.”

dicentra’s Toronto site will allow for fast recruitment of participants due to its downtown location being located on multiple transit routes, providing access to millions of potential participants within a 20-mile radius. dicentra prides itself on having the capacity to recruit participants quickly to meet the needs of clinical trial sponsors, offering a state-of-the-art clinical research clinic strategically located in the heart of Toronto, Canada.

To participate in this trial, or inquire about upcoming clinical trials, please visit: https://cannabis.vitalabs.clinic/

About Gaize

Gaize was created with a singular goal in mind. We see a world where the inevitable legalization of cannabis has been met with a technology that keeps roads and workplaces safe. We strongly believe that our approach is uniquely well suited to the challenges that cannabis impairment presents. We’re going to succeed because we must! https://www.gaize.ai/

About dicentra

dicentra is a leading Contract Research Organization (CRO) and global consulting firm that specializes in addressing all matters related to safety, quality, and compliance for all product categories in the life sciences and food industries. We evaluate, implement, and provide all the necessary support for products and operations to gain market access and build confidence in your brand. We achieve this through our three business divisions: consulting, clinical trials, and certifications. Since our inception in 2002, we have completed over 24,000 projects and serviced over 1,400 companies internationally. https://dicentra.com/

Share article on social media or email:

SightMD Welcomes Mukesh Kumar, MD to Their Expert Team in New York


News Image

When asked why he chose the SightMD team, Dr. Kumar said “I chose SightMD because I saw that they have the passion to always put the patient first. Whether it’s offering access to a clinic 7 days a week or having the latest vision correction technology in-office.”

SightMD, a leading multi-specialty ophthalmology platform in New York, welcomes Mukesh Kumar, MD to its expert team.

Dr. Mukesh Kumar, a comprehensive ophthalmologist, aims to give back to the community that has given him so much. His philosophy is to teach and involve the patient in their journey to improve and maintain their vision. Dr. Mukesh Kumar started his educational journey at Macaulay Honors College at City College of New York obtaining a degree in biochemistry. He then went on to achieve his Medical Degree from Hofstra/Northwell School of Medicine. Dr. Kumar is an active member of the American Academy of Ophthalmology, the Medical Society of the State Of New York and the American Medical Association. In his free time Dr Kumar enjoys traveling, hiking, and virtual reality. Dr. Kumar will be seeing patients at the SightMD Smithtown location (260 Middle Country Rd).

When asked why he chose the SightMD team, Dr. Kumar said “I chose SightMD because I saw that they have the passion to always put the patient first. Whether it’s offering access to a clinic 7 days a week or having the latest vision correction technology in-office. They also give the physician all the support and tools they need to focus on the patient instead of endless administrative tasks.”

SightMD is actively seeking ophthalmology professionals who are interested in joining our outstanding team. If you are an ophthalmology practice owner interested in merging or selling your practice, please contact our VP of Growth, Franc Galinanes, at (631) 396-8340 or fgalinanes@sightgrowthpartners.com

About SightMD

SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 80 eye care providers through the convenience of 40 locations across New York. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include general eye exams, laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD. For more information about SightMD, please visit https://www.sightmd.com/sightmd-ny/

Share article on social media or email: